ArticleClinical, cosmetic and investigational dermatology2026
Associations Between Psoriasis and Endocrine Diagnoses in a Tertiary-Center Electronic Health Record Database: A Cross-Sectional Study.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Purpose: Psoriasis is associated with systemic comorbidities such as cardiovascular disease. The purpose of this study is to assess whether patients with psoriasis are more likely to also have endocrine disorders. Patients and Methods: Using the Vanderbilt University Medical Center Synthetic Derivative, a de-identified database of more than 3.4 million patients, a cross-sectional study was conducted. PheWAS codes were used to identify patients with specific diagnoses. Results: The control cohort consisted of 3389683 patients (54.9% female) and the psoriasis cohort consisted of 10855 patients (55.5% female). The prevalence of several endocrine disorders was found to be higher in those with psoriasis than without, including Cushing's disease (0.322% vs 0.056%, age-adjusted odds ratio = 5.078, 95% CI = 3.650-7.066, p < 0.001), adrenal insufficiency (1.179% vs 0.225%, age-adjusted odds ratio = 4.388, 95% CI = 3.680-5.232, p < 0.001), hypothyroidism (10.567% vs 2.373%, age-adjusted odds ratio = 3.839, 95% CI = 3.607-4.085, p < 0.001), hyperthyroidism (1.704% vs 0.422%, age-adjusted odds ratio = 3.378, 95% CI = 2.919-3.910, p < 0.001), etc. Conclusion: These results suggest that patients with psoriasis may also be at risk for endocrine dysfunction. The consequences of systemic inflammation in patients with psoriasis may extend beyond metabolic disorders such as cardiovascular disease, and further investigation into the association between endocrine disorders and psoriasis may lead to improvements in the clinical management of the latter.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.